
NATURE . COM {
}
Title:
Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab | British Journal of Cancer
Description:
Phase III trials of the anti-insulin-like growth factor type 1 receptor (IGF-IR) antibody figitumumab (F) in unselected non-small-cell lung cancer (NSCLC) patients were recently discontinued owing to futility. Here, we investigated a role of free IGF-1 (fIGF-1) as a potential predictive biomarker of clinical benefit from F treatment. Pre-treatment circulating levels of fIGF-1 were tested in 110 advanced NSCLC patients enrolled in a phase II study of paclitaxel and carboplatin given alone (PC) or in combination with F at doses of 10 or 20 mg kg−1 (PCF10, PCF20). Cox proportional hazards model interactions were between 2.5 and 3.5 for fIGF-1 criteria in the 0.5–0.9 ng ml−1 range. Patients above each criterion had a substantial improvement in progression-free survival on PCF20 related to PC alone. Free IGF-1 correlated inversely with IGF binding protein 1 (IGFBP-1, ρ=−0.295, P=0.005), and the pre-treatment ratio of insulin to IGFBP-1 was also predictive of F clinical benefit. In addition, fIGF-1 levels correlated with tumour vimentin expression (ρ=0.594, P=0.021) and inversely with E-cadherin (ρ=–0.389, P=0.152), suggesting a role for fIGF-1 in tumour de-differentiation. Free IGF-1 may contribute to the identification of a subset of NSCLC patients who benefit from F therapy.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {📚}
- Education
- Science
- Health & Fitness
Content Management System {📝}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of nature.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {💰}
Display Ads {🎯}
$63,100 per month
According to our algorithms, Nature.com's monthly online income from display advertising ranges from $42,042 to $115,616.
Keywords {🔍}
patients, igf, figf, levels, cancer, article, growth, pcf, igfbp, google, scholar, insulin, nsclc, benefit, factor, cas, clinical, pfs, insulinlike, ratio, therapy, baseline, pretreatment, tumour, clin, nature, free, predictive, study, figure, gualberto, months, pollak, receptor, lung, bioactivity, data, igfir, binding, high, usa, circulating, treatment, criteria, analysis, identify, figitumumab, ecadherin, total, receiving,
Topics {✒️}
nature portfolio privacy policy research nature middle line represents advertising thermo scientific body mass index social media author information authors 0/ reprints italy assessing her2/neu amplification assessing k-ras mutations drug development full size image author correspondence eml4-alk gene fusion eml4-alk fusion gene open-label open label rabbit anti-pan-cytokeratin small-cell lung cancer pre-treatment circulating levels receiver-operating characteristic total alanine-scanning mutagenesis growth factor-binding proteins kaplan–meier curves plasma concentration–time curve low e-cadherin expression anti-igf-ir therapy high pre-treatment levels f-ihc aqua scores pre-treatment biomarker tests pre-treatment figf-1 levels binding protein-3-selective insulin chemotherapy-naïve stage iiib mouse anti-e-cadherin long-term clinical benefit tumour e-cadherin/vimentin ratio patients received pc significant biomarker/treatment interaction pre-treatment figf-1 criteria permissions small sample size egf receptor family progression-free survival clinical development dolled-filhart mp higher baseline levels
Schema {🗺️}
WebPage:
mainEntity:
headline:Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
description:Phase III trials of the anti-insulin-like growth factor type 1 receptor (IGF-IR) antibody figitumumab (F) in unselected non-small-cell lung cancer (NSCLC) patients were recently discontinued owing to futility. Here, we investigated a role of free IGF-1 (fIGF-1) as a potential predictive biomarker of clinical benefit from F treatment. Pre-treatment circulating levels of fIGF-1 were tested in 110 advanced NSCLC patients enrolled in a phase II study of paclitaxel and carboplatin given alone (PC) or in combination with F at doses of 10 or 20âmgâkgâ1 (PCF10, PCF20). Cox proportional hazards model interactions were between 2.5 and 3.5 for fIGF-1 criteria in the 0.5â0.9ângâmlâ1 range. Patients above each criterion had a substantial improvement in progression-free survival on PCF20 related to PC alone. Free IGF-1 correlated inversely with IGF binding protein 1 (IGFBP-1, Ï=â0.295, P=0.005), and the pre-treatment ratio of insulin to IGFBP-1 was also predictive of F clinical benefit. In addition, fIGF-1 levels correlated with tumour vimentin expression (Ï=0.594, P=0.021) and inversely with E-cadherin (Ï=â0.389, P=0.152), suggesting a role for fIGF-1 in tumour de-differentiation. Free IGF-1 may contribute to the identification of a subset of NSCLC patients who benefit from F therapy.
datePublished:2010-11-23T00:00:00Z
dateModified:2012-03-29T00:00:00Z
pageStart:68
pageEnd:74
sameAs:https://doi.org/10.1038/sj.bjc.6605972
keywords:
Drug therapy
Non-small-cell lung cancer
Predictive markers
IGF-IR
IGF-1
figitumumab
NSCLC
Biomedicine
general
Cancer Research
Epidemiology
Molecular Medicine
Oncology
Drug Resistance
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig5_HTML.jpg
isPartOf:
name:British Journal of Cancer
issn:
1532-1827
0007-0920
volumeNumber:104
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:A Gualberto
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:M L Hixon
affiliation:
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
type:Organization
type:Person
name:D D Karp
affiliation:
name:MD Anderson Cancer Center
address:
name:Department of Thoracic Oncology, MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:D Li
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
type:Person
name:S Green
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
type:Person
name:M Dolled-Filhart
affiliation:
name:HistoRx Inc.
address:
name:HistoRx Inc., New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:L G Paz-Ares
affiliation:
name:Virgen del Rocio University Hospital
address:
name:Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain
type:PostalAddress
type:Organization
type:Person
name:S Novello
affiliation:
name:University of Turin, Orbassano
address:
name:Department of Medical Oncology, University of Turin, Orbassano, Turin, Italy
type:PostalAddress
type:Organization
type:Person
name:J Blakely
affiliation:
name:West Clinic
address:
name:Department of Medical Oncology, West Clinic, Memphis, USA
type:PostalAddress
type:Organization
type:Person
name:C J Langer
affiliation:
name:Abramson Cancer Center, University of Pennsylvania
address:
name:Hematology/Oncology Division, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:M N Pollak
affiliation:
name:McGill University
address:
name:Department of Medical Oncology, McGill University, Montreal, Canada
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
description:Phase III trials of the anti-insulin-like growth factor type 1 receptor (IGF-IR) antibody figitumumab (F) in unselected non-small-cell lung cancer (NSCLC) patients were recently discontinued owing to futility. Here, we investigated a role of free IGF-1 (fIGF-1) as a potential predictive biomarker of clinical benefit from F treatment. Pre-treatment circulating levels of fIGF-1 were tested in 110 advanced NSCLC patients enrolled in a phase II study of paclitaxel and carboplatin given alone (PC) or in combination with F at doses of 10 or 20âmgâkgâ1 (PCF10, PCF20). Cox proportional hazards model interactions were between 2.5 and 3.5 for fIGF-1 criteria in the 0.5â0.9ângâmlâ1 range. Patients above each criterion had a substantial improvement in progression-free survival on PCF20 related to PC alone. Free IGF-1 correlated inversely with IGF binding protein 1 (IGFBP-1, Ï=â0.295, P=0.005), and the pre-treatment ratio of insulin to IGFBP-1 was also predictive of F clinical benefit. In addition, fIGF-1 levels correlated with tumour vimentin expression (Ï=0.594, P=0.021) and inversely with E-cadherin (Ï=â0.389, P=0.152), suggesting a role for fIGF-1 in tumour de-differentiation. Free IGF-1 may contribute to the identification of a subset of NSCLC patients who benefit from F therapy.
datePublished:2010-11-23T00:00:00Z
dateModified:2012-03-29T00:00:00Z
pageStart:68
pageEnd:74
sameAs:https://doi.org/10.1038/sj.bjc.6605972
keywords:
Drug therapy
Non-small-cell lung cancer
Predictive markers
IGF-IR
IGF-1
figitumumab
NSCLC
Biomedicine
general
Cancer Research
Epidemiology
Molecular Medicine
Oncology
Drug Resistance
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig5_HTML.jpg
isPartOf:
name:British Journal of Cancer
issn:
1532-1827
0007-0920
volumeNumber:104
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:A Gualberto
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:M L Hixon
affiliation:
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
type:Organization
type:Person
name:D D Karp
affiliation:
name:MD Anderson Cancer Center
address:
name:Department of Thoracic Oncology, MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:D Li
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
type:Person
name:S Green
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
type:Person
name:M Dolled-Filhart
affiliation:
name:HistoRx Inc.
address:
name:HistoRx Inc., New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:L G Paz-Ares
affiliation:
name:Virgen del Rocio University Hospital
address:
name:Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain
type:PostalAddress
type:Organization
type:Person
name:S Novello
affiliation:
name:University of Turin, Orbassano
address:
name:Department of Medical Oncology, University of Turin, Orbassano, Turin, Italy
type:PostalAddress
type:Organization
type:Person
name:J Blakely
affiliation:
name:West Clinic
address:
name:Department of Medical Oncology, West Clinic, Memphis, USA
type:PostalAddress
type:Organization
type:Person
name:C J Langer
affiliation:
name:Abramson Cancer Center, University of Pennsylvania
address:
name:Hematology/Oncology Division, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:M N Pollak
affiliation:
name:McGill University
address:
name:Department of Medical Oncology, McGill University, Montreal, Canada
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:British Journal of Cancer
issn:
1532-1827
0007-0920
volumeNumber:104
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
name:MD Anderson Cancer Center
address:
name:Department of Thoracic Oncology, MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
name:HistoRx Inc.
address:
name:HistoRx Inc., New Haven, USA
type:PostalAddress
name:Virgen del Rocio University Hospital
address:
name:Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain
type:PostalAddress
name:University of Turin, Orbassano
address:
name:Department of Medical Oncology, University of Turin, Orbassano, Turin, Italy
type:PostalAddress
name:West Clinic
address:
name:Department of Medical Oncology, West Clinic, Memphis, USA
type:PostalAddress
name:Abramson Cancer Center, University of Pennsylvania
address:
name:Hematology/Oncology Division, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
name:McGill University
address:
name:Department of Medical Oncology, McGill University, Montreal, Canada
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:A Gualberto
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
type:Organization
email:[email protected]
name:M L Hixon
affiliation:
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
type:Organization
name:D D Karp
affiliation:
name:MD Anderson Cancer Center
address:
name:Department of Thoracic Oncology, MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:D Li
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
name:S Green
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
name:M Dolled-Filhart
affiliation:
name:HistoRx Inc.
address:
name:HistoRx Inc., New Haven, USA
type:PostalAddress
type:Organization
name:L G Paz-Ares
affiliation:
name:Virgen del Rocio University Hospital
address:
name:Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain
type:PostalAddress
type:Organization
name:S Novello
affiliation:
name:University of Turin, Orbassano
address:
name:Department of Medical Oncology, University of Turin, Orbassano, Turin, Italy
type:PostalAddress
type:Organization
name:J Blakely
affiliation:
name:West Clinic
address:
name:Department of Medical Oncology, West Clinic, Memphis, USA
type:PostalAddress
type:Organization
name:C J Langer
affiliation:
name:Abramson Cancer Center, University of Pennsylvania
address:
name:Hematology/Oncology Division, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
name:M N Pollak
affiliation:
name:McGill University
address:
name:Department of Medical Oncology, McGill University, Montreal, Canada
type:PostalAddress
type:Organization
PostalAddress:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
name:Department of Thoracic Oncology, MD Anderson Cancer Center, Houston, USA
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
name:HistoRx Inc., New Haven, USA
name:Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain
name:Department of Medical Oncology, University of Turin, Orbassano, Turin, Italy
name:Department of Medical Oncology, West Clinic, Memphis, USA
name:Hematology/Oncology Division, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
name:Department of Medical Oncology, McGill University, Montreal, Canada
External Links {🔗}(103)
- https://doi.org/10.1038/bjc.2012.497's total income per month
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10404797
- http://scholar.google.com/scholar_lookup?&title=Changes%20in%20free%20insulin-like%20growth%20factor-1%20and%20leptin%20concentrations%20during%20acute%20metabolic%20decompensation%20in%20insulin%20withdrawn%20patients%20with%20type%201%20diabetes&journal=J%20Clin%20Endocrinol%20Metab&volume=84&pages=2324-2328&publication_year=1999&author=Attia%2CN&author=Caprio%2CS&author=Jones%2CTW&author=Heptulla%2CR&author=Holcombe%2CJ&author=Silver%2CD&author=Sherwin%2CRS&author=Tamborlane%2CWV's total income per month
- What's the monthly income of https://doi.org/10.1046%2Fj.1365-2265.1996.7760786.x?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Insulin%20treatment%20normalizes%20reduced%20free%20insulin-like%20growth%20factor-I%20concentrations%20in%20diabetic%20children&journal=Clin%20Endocrinol%20%28Oxf%29&doi=10.1046%2Fj.1365-2265.1996.7760786.x&volume=45&pages=321-326&publication_year=1996&author=Bereket%2CA&author=Lang%2CCH&author=Blethen%2CSL&author=Ng%2CLC&author=Wilson%2CTA generate?
- Earnings of https://doi.org/10.1258%2F000456307780945778
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=The%20biochemical%20assessment%20of%20insulin%20resistance&journal=Ann%20Clin%20Biochem&doi=10.1258%2F000456307780945778&volume=44&pages=324-342&publication_year=2007&author=Borai%2CA&author=Livingstone%2CC&author=Ferns%2CGA?
- Revenue of https://doi.org/10.1210%2Fjc.2007-2454
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Normal%20values%20of%20circulating%20insulin-like%20growth%20factor-I%20bioactivity%20in%20the%20healthy%20population%3A%20comparison%20with%20five%20widely%20used%20IGF-1%20immunoassays&journal=J%20Clin%20Endocrinol%20Metab&doi=10.1210%2Fjc.2007-2454&volume=93&pages=2539-2545&publication_year=2008&author=Brugts%2CMP&author=Ranke%2CMB&author=Hofland%2CLJ&author=van%20der%20Wansem%2CK&author=Weber%2CK&author=Frystyk%2CJ&author=Lamberts%2CSW&author=Janssen%2CJA bring in?
- Find out how much https://doi.org/10.1210%2Fjc.2007-1633 earns monthly
- How much does http://scholar.google.com/scholar_lookup?&title=Low%20circulating%20insulin-like%20growth%20factor%20I%20bioactivity%20in%20elderly%20men%20is%20associated%20with%20increased%20mortality&journal=J%20Clin%20Endocrinol%20Metab&doi=10.1210%2Fjc.2007-1633&volume=93&pages=2515-2522&publication_year=2008&author=Brugts%2CMP&author=van%20den%20Beld%2CAW&author=Hofland%2CLJ&author=van%20der%20Wansem%2CK&author=van%20Koetsveld%2CPM&author=Frystyk%2CJ&author=Lamberts%2CSW&author=Janssen%2CJA rake in every month?
- Get to know what's the income of https://doi.org/10.2337%2Fdb09-0583
- How much does http://scholar.google.com/scholar_lookup?&title=Igf-I%20bioactivity%20in%20an%20elderly%20population%3A%20relation%20to%20insulin%20sensitivity%2C%20insulin%20levels%2C%20and%20the%20metabolic%20syndrome&journal=Diabetes&doi=10.2337%2Fdb09-0583&volume=59&pages=505-508&publication_year=2010&author=Brugts%2CMP&author=van%20Duijn%2CCM&author=Hofland%2CLJ&author=Witteman%2CJC&author=Lamberts%2CSW&author=Janssen%2CJA rake in every month?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12473592?
- How much does http://scholar.google.com/scholar_lookup?&title=Clinical%20significance%20of%20insulin-like%20growth%20factor-binding%20protein-3%20expression%20in%20stage%20I%20non-small%20cell%20lung%20cancer&journal=Clin%20Cancer%20Res&volume=8&pages=3796-3802&publication_year=2002&author=Chang%2CYS&author=Kong%2CG&author=Sun%2CS&author=Liu%2CD&author=El-Naggar%2CAK&author=Khuri%2CFR&author=Hong%2CWK&author=Lee%2CHY earn?
- Get to know https://doi.org/10.1158%2F1078-0432.CCR-07-4879's earnings
- How much income does http://scholar.google.com/scholar_lookup?&title=The%20type%201%20insulin-like%20growth%20factor%20receptor%20pathway&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-4879&volume=14&pages=6364-6370&publication_year=2008&author=Chitnis%2CMM&author=Yuen%2CJS&author=Protheroe%2CAS&author=Pollak%2CM&author=Macaulay%2CVM have?
- What's the monthly money flow for https://doi.org/10.1158%2F1078-0432.CCR-04-1070?
- How much does http://scholar.google.com/scholar_lookup?&title=Combination%20therapy%20enhances%20the%20inhibition%20of%20tumor%20growth%20with%20the%20fully%20human%20anti-type%201%20insulin-like%20growth%20factor%20receptor%20monoclonal%20antibody%20CP-751%2C871&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-04-1070&volume=11&pages=2063-2073&publication_year=2005&author=Cohen%2CBD&author=Baker%2CDA&author=Soderstrom%2CC&author=Tkalcevic%2CG&author=Rossi%2CAM&author=Miller%2CPE&author=Tengowski%2CMW&author=Wang%2CF&author=Gualberto%2CA&author=Beebe%2CJS&author=Moyer%2CJD earn?
- How much revenue does https://doi.org/10.1021%2Fbi990089p bring in?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Total%20alanine-scanning%20mutagenesis%20of%20insulin-like%20growth%20factor%20I%20%28IGF-1%29%20identifies%20differential%20binding%20epitopes%20for%20IGFBP-1%20and%20IGFBP-3&journal=Biochemistry&doi=10.1021%2Fbi990089p&volume=38&pages=6386-6396&publication_year=1999&author=Dubaqui%C3%A9%2CY&author=Lowman%2CHB bring in?
- Monthly income for https://doi.org/10.1210%2Fendo.142.1.7864
- How profitable is http://scholar.google.com/scholar_lookup?&title=Binding%20protein-3-selective%20insulin-like%20growth%20factor%20I%20variants%3A%20engineering%2C%20biodistributions%2C%20and%20clearance&journal=Endocrinology&doi=10.1210%2Fendo.142.1.7864&volume=142&pages=165-173&publication_year=2001&author=Dubaqui%C3%A9%2CY&author=Mortensen%2CDL&author=Intintoli%2CA&author=Hogue%2CDA&author=Nakamura%2CG&author=Rancatore%2CP&author=Lester%2CP&author=Sadick%2CMD&author=Filvaroff%2CE&author=Fielder%2CPJ&author=Lowman%2CHB?
- How much does https://doi.org/10.1002%2Fijc.2910560618 earn?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Expression%20and%20function%20of%20the%20insulin%20like%20growth%20factor%201%20system%20in%20human%20non%20small%20cell%20lung%20cancer%20and%20normal%20lung%20cell%20lines&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.2910560618&volume=56&pages=858-866&publication_year=1994&author=Favoni%2CRE&author=de%20Cupis%2CA&author=Ravera%2CF&author=Cantoni%2CC&author=Pirani%2CP&author=Ardizzoni%2CA&author=Noonan%2CD&author=Biassoni%2CR?
- Get to know what's the income of https://link.springer.com/doi/10.1007/s11102-007-0025-y
- See how much http://scholar.google.com/scholar_lookup?&title=Utility%20of%20free%20IGF-1%20measurements&journal=Pituitary&doi=10.1007%2Fs11102-007-0025-y&volume=10&pages=181-187&publication_year=2007&author=Frystyk%2CJ makes per month
- https://doi.org/10.1517%2F14712591003689980's revenue stream
- How much profit does http://scholar.google.com/scholar_lookup?&title=Figitumumab%20%28CP-751%2C871%29%20for%20cancer%20therapy&journal=Expert%20Opin%20Biol%20Ther&doi=10.1517%2F14712591003689980&volume=10&pages=575-585&publication_year=2010&author=Gualberto%2CA make?
- How much profit does https://doi.org/10.1200%2FJCO.2008.21.7695 make?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Molecular%20basis%20for%20sensitivity%20to%20figitumumab%20%28CP-751%2C871%29%20in%20NSCLC&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2008.21.7695&volume=27&publication_year=2009&author=Gualberto%2CA&author=Dolled-Filhart%2CMP&author=Hixon%2CML&author=Christensen%2CJ&author=Rimm%2CDL&author=Lee%2CAV&author=Wang%2CY&author=Pollak%2CM&author=Paz-Ares%2CLG&author=Karp%2CDD earns monthly
- Earnings of https://doi.org/10.1038%2Fonc.2009.172
- Income figures for http://scholar.google.com/scholar_lookup?&title=Emerging%20role%20of%20insulin-like%20growth%20factor%20receptor%20inhibitors%20in%20oncology%3A%20early%20clinical%20trial%20results%20and%20future%20directions&journal=Oncogene&doi=10.1038%2Fonc.2009.172&volume=28&pages=3009-3021&publication_year=2009&author=Gualberto%2CA&author=Pollak%2CM
- How much revenue does https://doi.org/10.1016%2Fj.lungcan.2006.07.014 bring in?
- How much does http://scholar.google.com/scholar_lookup?&title=The%20prognostic%20significance%20of%20pretreatment%20plasma%20levels%20of%20insulin-like%20growth%20factor%20%28IGF%29-1%2C%20IGF-2%2C%20and%20IGF%20binding%20protein-3%20in%20patients%20with%20advanced%20non-small%20cell%20lung%20cancer&journal=Lung%20Cancer&doi=10.1016%2Fj.lungcan.2006.07.014&volume=54&pages=227-234&publication_year=2006&author=Han%2CJY&author=Choi%2CBG&author=Choi%2CJY&author=Lee%2CSY&author=Ju%2CSY pull in?
- How much revenue does https://doi.org/10.1161%2F01.ATV.18.2.277 produce monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Serum%20total%20IGF-1%2C%20free%20IGF-1%2C%20and%20IGFB-1%20levels%20in%20an%20elderly%20population%3A%20relation%20to%20cardiovascular%20risk%20factors%20and%20disease&journal=Arterioscler%20Thromb%20Vasc%20Biol&doi=10.1161%2F01.ATV.18.2.277&volume=18&pages=277-282&publication_year=1998&author=Janssen%2CJA&author=Stolk%2CRP&author=Pols%2CHA&author=Grobbee%2CDE&author=Lamberts%2CSW earn?
- What's the monthly money flow for https://doi.org/10.1200%2Fjco.2010.28.15_suppl.7500?
- Get to know http://scholar.google.com/scholar_lookup?&title=Randomized%2C%20open%20label%2C%20phase%20III%20trial%20of%20figitumumab%20in%20combination%20with%20paclitaxel%20and%20carboplatin%20versus%20paclitaxel%20and%20carboplatin%20in%20patients%20with%20non-small%20cell%20lung%20cancer%20%28NSCLC%29&journal=J%20Clin%20Oncol&doi=10.1200%2Fjco.2010.28.15_suppl.7500&volume=28&publication_year=2010&author=Jassem%2CJ&author=Langer%2CCJ&author=Karp%2CDD&author=Mok%2CT&author=Benner%2CRJ&author=Green%2CSJ&author=Park%2CK&author=Novello%2CS&author=Strausz%2CJ&author=Gualberto%2CA's earnings
- How much profit does http://scholar.google.com/scholar_lookup?&title=The%20role%20of%20insulin-like%20growth%20factors%20in%20the%20epithelial%20to%20mesenchymal%20transition&publication_year=2005&author=Julien-Grille%2CS&author=Moore%2CR&author=Denat%2CL&author=Morali%2COG&author=Delmas%2CV&author=Bellacosa%2CA&author=Laure%2CL generate?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9253324 making per month?
- http://scholar.google.com/scholar_lookup?&title=Free%20insulin-like%20growth%20factor%20I%20serum%20levels%20in%201430%20healthy%20children%20and%20adults%2C%20and%20its%20diagnostic%20value%20in%20patients%20suspected%20of%20growth%20hormone%20deficiency&journal=J%20Clin%20Endocrinol%20Metab&volume=82&pages=2497-2502&publication_year=1997&author=Juul%2CA&author=Holm%2CK&author=Kastrup%2CKW&author=Pedersen%2CSA&author=Michaelsen%2CKF&author=Scheike%2CT&author=Rasmussen%2CS&author=M%C3%BCller%2CJ&author=Skakkebaek%2CNE's revenue stream
- What's the income of https://doi.org/10.1172%2FJCI39104?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=The%20basics%20of%20epithelial%E2%80%93mesenchymal%20transition&journal=J%20Clin%20Invest&doi=10.1172%2FJCI39104&volume=119&pages=1420-1428&publication_year=2009&author=Kalluri%2CR&author=Weinberg%2CRA
- How much does https://doi.org/10.1200%2FJCO.2008.19.9331 net monthly?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Phase%20II%20study%20of%20the%20anti-insulin-like%20growth%20factor%20type%201%20receptor%20antibody%20CP-751%2C871%20in%20combination%20with%20paclitaxel%20and%20carboplatin%20in%20previously%20untreated%2C%20locally%20advanced%2C%20or%20metastatic%20non-small-cell%20lung%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2008.19.9331&volume=27&pages=2516-2522&publication_year=2009&author=Karp%2CDD&author=Paz-Ares%2CLG&author=Novello%2CS&author=Haluska%2CP&author=Garland%2CL&author=Cardenal%2CF&author=Blakely%2CLJ&author=Eisenberg%2CPD&author=Langer%2CCJ&author=Blumenschein%2CG&author=Johnson%2CFM&author=Green%2CS&author=Gualberto%2CA?
- What's the financial outcome of https://doi.org/10.1016%2F1357-2725%2896%2900005-2?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor-binding%20proteins%20%28IGFBPs%29%20and%20their%20regulatory%20dynamics&journal=Int%20J%20Biochem%20Cell%20Biol&doi=10.1016%2F1357-2725%2896%2900005-2&volume=28&pages=619-637&publication_year=1996&author=Kelley%2CKM&author=Oh%2CY&author=Gargosky%2CSE&author=Gucev%2CZ&author=Matsumoto%2CT&author=Hwa%2CV&author=Ng%2CL&author=Simpson%2CDM&author=Rosenfeld%2CRG?
- https://doi.org/10.1158%2F1078-0432.CCR-08-0168 income
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=EML4-ALK%20fusion%20gene%20and%20efficacy%20of%20an%20ALK%20kinase%20inhibitor%20in%20lung%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-08-0168&volume=14&pages=4275-4283&publication_year=2008&author=Koivunen%2CJP&author=Mermel%2CC&author=Zejnullahu%2CK&author=Murphy%2CC&author=Lifshits%2CE&author=Holmes%2CAJ&author=Choi%2CHG&author=Kim%2CJ&author=Chiang%2CD&author=Thomas%2CR&author=Lee%2CJ&author=Richards%2CWG&author=Sugarbaker%2CDJ&author=Ducko%2CC&author=Lindeman%2CN&author=Marcoux%2CJP&author=Engelman%2CJA&author=Gray%2CNS&author=Lee%2CC&author=Meyerson%2CM&author=J%C3%A4nne%2CPA each month?
- How much revenue does https://doi.org/10.3181%2F00379727-204-43630 bring in?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Regulation%20and%20function%20of%20insulin-like%20growth%20factor%20binding%20protein-1&journal=Proc%20Soc%20Exp%20Biol%20Med&doi=10.3181%2F00379727-204-43630&volume=204&pages=4-29&publication_year=1993&author=Lee%2CPD&author=Conover%2CCA&author=Powell%2CDR earns monthly
- Get to know what's the income of https://doi.org/10.1038%2Fsj.onc.1204660
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=IGF-2%20induces%20rapid%20beta-catenin%20relocation%20to%20the%20nucleus%20during%20epithelium%20to%20mesenchyme%20transition&journal=Oncogene&doi=10.1038%2Fsj.onc.1204660&volume=20&pages=4942-4950&publication_year=2001&author=Morali%2COG&author=Delmas%2CV&author=Moore%2CR&author=Jeanney%2CC&author=Thiery%2CJP&author=Larue%2CL
- https://doi.org/10.2337%2Fdiabetes.50.1.32 income
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Physiological%20differences%20in%20insulin-like%20growth%20factor%20binding%20protein-1%20%28IGFBP-1%29%20phosphorylation%20in%20IGFBP-1%20transgenic%20mice&journal=Diabetes&doi=10.2337%2Fdiabetes.50.1.32&volume=50&pages=32-38&publication_year=2001&author=Sakai%2CK&author=D%E2%80%99Ercole%2CAJ&author=Murphy%2CLJ&author=Clemmons%2CDR
- How much income is https://doi.org/10.1073%2Fpnas.210394297 earning monthly?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor%201%20regulates%20the%20location%2C%20stability%2C%20and%20transcriptional%20activity%20of%20beta-catenin&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.210394297&volume=9&pages=12103-12108&publication_year=2000&author=Playford%2CMP&author=Bicknell%2CD&author=Bodmer%2CWF&author=Macaulay%2CVM?
- How much profit is https://doi.org/10.1038%2Fnrc2536 making per month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Insulin%20and%20insulin-like%20growth%20factor%20signalling%20in%20neoplasia&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2536&volume=8&pages=915-928&publication_year=2008&author=Pollak%2CM generate?
- Learn how profitable https://doi.org/10.1093%2Fjnci%2Fdjp280 is on a monthly basis
- How much does http://scholar.google.com/scholar_lookup?&title=Biomarkers%20predicting%20clinical%20outcome%20of%20epidermal%20growth%20factor%20receptor-targeted%20therapy%20in%20metastatic%20colorectal%20cancer&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2Fdjp280&volume=101&pages=1308-1324&publication_year=2009&author=Siena%2CS&author=Sartore-Bianchi%2CA&author=Di%20Nicolantonio%2CF&author=Balfour%2CJ&author=Bardelli%2CA generate monthly?
- Get to know https://doi.org/10.1200%2FJCO.2007.14.8197's earnings
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Guidelines%20for%20human%20epidermal%20growth%20factor%20receptor%202%20testing%3A%20biologic%20and%20methodologic%20considerations&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2007.14.8197&volume=27&pages=1323-1333&publication_year=2009&author=Sauter%2CG&author=Lee%2CJ&author=Bartlett%2CJM&author=Slamon%2CDJ&author=Press%2CMF?
- Explore the financials of https://doi.org/10.1200%2FJCO.2009.26.3996
- What's http://scholar.google.com/scholar_lookup?&title=Epidermal%20growth%20factor%20receptor%20biomarkers%20in%20non-small-cell%20lung%20cancer%3A%20a%20riddle%2C%20wrapped%20in%20a%20mystery%2C%20inside%20an%20enigma&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2009.26.3996&volume=28&pages=903-905&publication_year=2010&author=Shepherd%2CFA&author=Tsao%2CMS's gross income?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12433720's revenue stream
- What's http://scholar.google.com/scholar_lookup?&title=Serum%20insulin%20like%20growth%20factor%20%28IGF%29%20and%20IGF%20binding%20protein%20levels%20and%20risk%20of%20lung%20cancer%3A%20a%20case%20control%20study%20nested%20in%20the%20beta%20carotene%20and%20retinol%20efficacy%20trial%20cohort&journal=Cancer%20Epidemiol%20Biomarkers%20Prev&volume=11&pages=1413-1418&publication_year=2002&author=Spitz%2CMR&author=Barnett%2CMJ&author=Goodman%2CGE&author=Thornquist%2CMD&author=Wu%2CX&author=Pollak%2CM's gross income?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Receiver-operating%20characteristic%20%28ROC%29%20plots%3A%20a%20fundamental%20evaluation%20tool%20in%20clinical%20medicine&journal=Clin%20Chem&volume=39&pages=561-577&publication_year=1993&author=Zweig%2CMH&author=Campbell%2CG?
- Financial intake of https://citation-needed.springer.com/v2/references/10.1038/sj.bjc.6605972?format=refman&flavour=references
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=A%20Gualberto make?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22A%20Gualberto%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M%20L%20Hixon?
- How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M%20L%20Hixon%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D%20D%20Karp gross monthly?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D%20D%20Karp%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D%20Li?
- What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S%20Green?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S%20Green%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
- What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M%20Dolled-Filhart?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M%20Dolled-Filhart%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
- Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=L%20G%20Paz-Ares
- What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22L%20G%20Paz-Ares%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S%20Novello?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S%20Novello%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J%20Blakely?
- Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J%20Blakely%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=C%20J%20Langer?
- What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22C%20J%20Langer%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M%20N%20Pollak?
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M%20N%20Pollak%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the profit of https://s100.copyright.com/AppDispatchServlet?title=Pre-treatment%20levels%20of%20circulating%20free%20IGF-1%20identify%20NSCLC%20patients%20who%20derive%20clinical%20benefit%20from%20figitumumab&author=A%20Gualberto%20et%20al&contentID=10.1038%2Fsj.bjc.6605972©right=The%20Author%28s%29&publication=0007-0920&publicationDate=2010-11-23&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY-NC-SA?
- How profitable is https://citation-needed.springer.com/v2/references/10.1038/sj.bjc.6605972?format=refman&flavour=citation?
- How much income is https://doi.org/10.1186/s13045-018-0616-2 earning monthly?
- What are the earnings of https://doi.org/10.1038/nrc3215?
- How much money does https://doi.org/10.1007/s10911-012-9268-y generate?
- How much does https://doi.org/10.1038/bjc.2011.412 net monthly?
- Find out how much https://doi.org/10.1038/bjc.2011.413 earns monthly
- What is the monthly revenue of https://www.protocols.io/?
- Earnings of https://www.natureindex.com/
- What's the financial intake of http://www.naturechina.com?
- Learn about the earnings of https://www.natureasia.com/ja-jp
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Prism.js
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {📦}
- Crossref